Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Dec 1;178(6):2089–2096. doi: 10.1084/jem.178.6.2089

High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood

PMCID: PMC2191297  PMID: 7504056

Abstract

Umbilical cord blood is rich in hematopoietic stem and progenitor cells and has recently been used successfully in the clinic as an alternative source of engrafting and marrow repopulating cells. With the likelihood that cord blood stem/progenitor cells will be used for gene therapy to correct genetic disorders, we evaluated if a TK-neo gene could be directly transduced in a stable manner into single isolated subsets of purified immature hematopoietic cells that demonstrate self-renewed ability as estimated by colony replating capacity. Sorted CD34(3+) cells from cord blood were prestimulated with erythropoietin (Epo), steel factor (SLF), interleukin (IL)-3, and granulocyte-macrophage colony stimulating factor (GM-CSF) and transduced with the gene in two ways. CD34(3+) cells were incubated with retroviral-containing supernatant from TK-neo vector-producing cells, washed, and plated directly or resorted as CD34(3+) cells into single wells containing a single cell or 10 cells. Alternatively, CD34(3+) cells were sorted as a single cell/well and then incubated with viral supernatant. These cells were cultured with Epo, SLF, IL-3, and GM-CSF +/- G418. The TK-neo gene was introduced at very high efficiency into low numbers of or isolated single purified CD34(3+) immature hematopoietic cells without stromal cells as a source of virus or accessory cells. Proviral integration was detected in primary G418-resistant(R) colonies derived from single immature hematopoietic cells, and in cells from replated colonies derived from G418R-colony forming unit-granulocyte erythroid macrophage megakaryocyte (CFU-GEMM) and -high proliferative potential colony forming cells (HPP-CFC). This demonstrates stable expression of the transduced gene into single purified stem/progenitor cells with replating capacity, results that should be applicable for future clinical studies that may utilize selected subsets of stem/progenitor cells for gene therapy.

Full Text

The Full Text of this article is available as a PDF (852.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum C. M., Weissman I. L., Tsukamoto A. S., Buckle A. M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2804–2808. doi: 10.1073/pnas.89.7.2804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernstein I. D., Andrews R. G., Zsebo K. M. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood. 1991 Jun 1;77(11):2316–2321. [PubMed] [Google Scholar]
  3. Broxmeyer H. E., Douglas G. W., Hangoc G., Cooper S., Bard J., English D., Arny M., Thomas L., Boyse E. A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989 May;86(10):3828–3832. doi: 10.1073/pnas.86.10.3828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Broxmeyer H. E., Hangoc G., Cooper S., Ribeiro R. C., Graves V., Yoder M., Wagner J., Vadhan-Raj S., Benninger L., Rubinstein P. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4109–4113. doi: 10.1073/pnas.89.9.4109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broxmeyer H. E., Sherry B., Lu L., Cooper S., Oh K. O., Tekamp-Olson P., Kwon B. S., Cerami A. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood. 1990 Sep 15;76(6):1110–1116. [PubMed] [Google Scholar]
  6. Cardoso A. A., Li M. L., Batard P., Hatzfeld A., Brown E. L., Levesque J. P., Sookdeo H., Panterne B., Sansilvestri P., Clark S. C. Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8707–8711. doi: 10.1073/pnas.90.18.8707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carow C. E., Hangoc G., Broxmeyer H. E. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma. Blood. 1993 Feb 15;81(4):942–949. [PubMed] [Google Scholar]
  8. Carow C. E., Hangoc G., Cooper S. H., Williams D. E., Broxmeyer H. E. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood. 1991 Nov 1;78(9):2216–2221. [PubMed] [Google Scholar]
  9. Cassel A., Cottler-Fox M., Doren S., Dunbar C. E. Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol. 1993 Apr;21(4):585–591. [PubMed] [Google Scholar]
  10. Eglitis M. A., Kantoff P., Gilboa E., Anderson W. F. Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science. 1985 Dec 20;230(4732):1395–1398. doi: 10.1126/science.2999985. [DOI] [PubMed] [Google Scholar]
  11. Ferrari G., Rossini S., Nobili N., Maggioni D., Garofalo A., Giavazzi R., Mavilio F., Bordignon C. Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions. Blood. 1992 Sep 1;80(5):1120–1124. [PubMed] [Google Scholar]
  12. Gansbacher B., Zier K., Cronin K., Hantzopoulos P. A., Bouchard B., Houghton A., Gilboa E., Golde D. Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood. 1992 Dec 1;80(11):2817–2825. [PubMed] [Google Scholar]
  13. Gluckman E., Broxmeyer H. A., Auerbach A. D., Friedman H. S., Douglas G. W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989 Oct 26;321(17):1174–1178. doi: 10.1056/NEJM198910263211707. [DOI] [PubMed] [Google Scholar]
  14. Kantoff P. W., Gillio A. P., McLachlin J. R., Bordignon C., Eglitis M. A., Kernan N. A., Moen R. C., Kohn D. B., Yu S. F., Karson E. Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J Exp Med. 1987 Jul 1;166(1):219–234. doi: 10.1084/jem.166.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Keller G., Paige C., Gilboa E., Wagner E. F. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature. 1985 Nov 14;318(6042):149–154. doi: 10.1038/318149a0. [DOI] [PubMed] [Google Scholar]
  16. Lim B., Apperley J. F., Orkin S. H., Williams D. A. Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8892–8896. doi: 10.1073/pnas.86.22.8892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lu L., Walker D., Broxmeyer H. E., Hoffman R., Hu W., Walker E. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J Immunol. 1987 Sep 15;139(6):1823–1829. [PubMed] [Google Scholar]
  18. Miller A. D., Eckner R. J., Jolly D. J., Friedmann T., Verma I. M. Expression of a retrovirus encoding human HPRT in mice. Science. 1984 Aug 10;225(4662):630–632. doi: 10.1126/science.6377498. [DOI] [PubMed] [Google Scholar]
  19. Moritz T., Keller D. C., Williams D. A. Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med. 1993 Aug 1;178(2):529–536. doi: 10.1084/jem.178.2.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nolta J. A., Crooks G. M., Overell R. W., Williams D. E., Kohn D. B. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: effects of mast cell growth factor (MGF) combined with other cytokines. Exp Hematol. 1992 Oct;20(9):1065–1071. [PubMed] [Google Scholar]
  21. Pharr P. N., Hankins D., Hofbauer A., Lodish H. F., Longmore G. D. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):938–942. doi: 10.1073/pnas.90.3.938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vilmer E., Sterkers G., Rahimy C., Denamur E., Elion J., Broyart A., Lescoeur B., Tiercy J. M., Gerota J., Blot P. HLA-mismatched cord-blood transplantation in a patient with advanced leukemia. Transplantation. 1992 May;53(5):1155–1157. [PubMed] [Google Scholar]
  23. Wagner J. E., Broxmeyer H. E., Byrd R. L., Zehnbauer B., Schmeckpeper B., Shah N., Griffin C., Emanuel P. D., Zuckerman K. S., Cooper S. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood. 1992 Apr 1;79(7):1874–1881. [PubMed] [Google Scholar]
  24. Williams D. A., Hsieh K., DeSilva A., Mulligan R. C. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med. 1987 Jul 1;166(1):210–218. doi: 10.1084/jem.166.1.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Williams D. A., Lemischka I. R., Nathan D. G., Mulligan R. C. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature. 1984 Aug 9;310(5977):476–480. doi: 10.1038/310476a0. [DOI] [PubMed] [Google Scholar]
  26. Williams D. A., Orkin S. H. Somatic gene therapy. Current status and future prospects. J Clin Invest. 1986 Apr;77(4):1053–1056. doi: 10.1172/JCI112403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Winberg G. A rapid method for preparing DNA from blood, suited for PCR screening of transgenes in mice. PCR Methods Appl. 1991 Aug;1(1):72–74. doi: 10.1101/gr.1.1.72. [DOI] [PubMed] [Google Scholar]
  28. Xiao M., Leemhuis T., Broxmeyer H. E., Lu L. Influence of combinations of cytokines on proliferation of isolated single cell-sorted human bone marrow hematopoietic progenitor cells in the absence and presence of serum. Exp Hematol. 1992 Feb;20(2):276–279. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES